This approach hasbeen successfully used both in vitro and in vivoto study CD19- and mesothelin-specific CARs [90, 91].Mesothelin-specific CARs have been subsequently successfully applied to treatpancreatic cancer [92, 93]. The gene discussed is MSLN; the disease is cancer.